Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06529302 · ClinicalTrials.gov registry record
The OPBC-07/microNAC Study
A clinical trial of Breast Cancer, sponsored by University Hospital, Basel, Switzerland.
- Active
- Registry status
- 2,000
- Enrollment target
- 20
- Study locations
NCT06529302 is a study of Breast Cancer that is active but no longer recruiting, run by University Hospital, Basel, Switzerland. The registered enrollment target is 2,000 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (29% lower). The trial reports 20 study locations across 12 states.
The verdict
NCT06529302, a study of Breast Cancer, is active but no longer recruiting, sponsored by University Hospital, Basel, Switzerland.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The aim of this multicenter retrospective cohort study is to determine the safety of omission of axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy.
Conditions Studied
Study Locations (20)
New York
- NYU Langone Health - New York
- Memorial Sloan Kettering Cancer Center - New York
- Montefiore Medical Center - New York
- University of Rochester - Rochester
California
- Cedars-Sinai Medical Center - Los Angeles
- University of California - San Francisco
- Providence Saint John's Cancer Institute - Santa Monica
Pennsylvania
- University of Pennsylvania - Philadelphia
- Fox Chase Cancer Center - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
Washington
- Swedish Cancer Institute - Seattle
- University of Washington - Seattle
Arizona
- Valleywise Health Medical Center - Phoenix
Florida
- University of Miami - Coral Gables
Massachusetts
- Dana-Farber Cancer Institute - Boston
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2025-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06529302
The ClinicalTrials.gov registry entry for NCT06529302 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (29% lower). The listed sponsor is University Hospital, Basel, Switzerland, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT06529302 reports 20 study locations spanning 12 distinct geographic areas - top geographies include New York, California, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06529302 about?
NCT06529302 is a clinical study titled "The OPBC-07/microNAC Study". The aim of this multicenter retrospective cohort study is to determine the safety of omission of axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy.
What is the current status of trial NCT06529302?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2024-05-15. Estimated completion is 2025-06.
What conditions does trial NCT06529302 study?
This clinical trial studies the following conditions: Breast Cancer.
Who is sponsoring clinical trial NCT06529302?
This trial is sponsored by University Hospital, Basel, Switzerland, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06529302 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.